Hyperfine, Inc. (ticker: HYPR) is an NASDAQ-listed electromedical & electrotherapeutic apparatus company. DredgeCap's structured extraction of HYPR's SEC filings surfaces 3 active risk signals, including 2 late-filing signals, and 1 auditor-change signal. HYPR reported $3.90M in revenue and -$8.62M for the period ending 2026-03-31, with operating cash flow of -$9.01M. Cash and equivalents stood at $40.78M (up 23.2% year-over-year). Total assets of $60.34M exceed total liabilities of $25.98M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
HYPR SEC Filings
Full cached SEC EDGAR filing history for HYPR, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.